Virilization Panel 2
Also known as: VIRIL PAN2
Use
The Virilization Panel 2 aids in the detection of nonclassical congenital adrenal hyperplasia in individuals presenting with hyperandrogenism. This panel includes several hormone tests that measure levels of testosterone, 17-Hydroxyprogesterone, androstenedione, and dehydroepiandrosterone, which are critical in assessing hormonal imbalances and contributing to the diagnosis of conditions affecting adrenal gland function.
Special Instructions
Blood samples must be drawn between 6-10 a.m. for optimal hormone level accuracy, and the serum or plasma must be separated from cells within 2 hours of collection. The samples should be transferred to an ARUP Standard Transport Tube for transport.
Limitations
The test has been developed and performance characteristics determined by ARUP Laboratories but has not been cleared or approved by the US Food and Drug Administration. It is performed in a CLIA certified laboratory. Free or bioavailable testosterone measurements may provide supportive information. However, for individuals on testosterone-suppressing hormone therapies, refer to cisgender female reference intervals.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 2986-8
- 1668-3
- 1854-9
- 2193-1
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.2 mL
Minimum Volume
0.7 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect between 6-10 a.m. and separate serum or plasma from cells ASAP or within 2 hours of collection.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 1 week |
| Frozen | 6 months |